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The sequential changes induced by histamine and com-
pound 48/80 in normal skin were studied by light and 
electron microscopy. 
Histamine (50 p.g) or compound 48/80 (10 p.g) was 
injected intradermally as a single bolus, a repeated bolus 
every 15 min for 2 hr, or as a constant infusion (120 p.g 
histamine/hr; 24 p.g compound 48/80 hr) for 4 hr. Skin 
biopsies were taken 15 min to 24 hr after injection and 
cellular and other morphological changes were assessed 
in 1 p.m Epon sections by light microscopy. 
Fifteen minutes after a single bolus of histamine there 
was dilatation of dermal vessels, endothelial swelling, 
fibrin deposition, perivascular edema and slight mast 
cell degranulation. At 4 hr these edema-related changes 
had largely regressed. Perivascular leukocytes were 
usually absent. After repeated bolus injections or contin-
uous infusions of histamine a slight infiltrate of neutro-
phils, eosinophils and mononuclear cells was seen 
around venules. 
After a single injection of compound 48/80 there was 
a perivascular infiltration ofneutrophils and eosinophils 
that was slight to moderate at 15-30 min and greater at 
24 hr. Electron microscopy showed that many of these 
leukocytes had undergone degranulation or lysis even 
within vessel lumina. Exocytotic mast cell degranulation 
was mor.e extensive with compound 48/80 than with 
histamine or with phosphate buffered saline. There was 
marked variation in both the number of mast cells un-
dergoing degranulation and the degree of degranulation 
in individual cells. 
We conclude that the greater cellular reaction caused 
by compound 48/80 probably depends upon release from 
mast cells of mediators other than histamine. The con-
tribution of fibrin in acute dermal inflammation needs 
to be examined further. 
The role of histamine as a mediator of acute inflammation is 
well recognized [1] and its important effects on skin blood 
vessels have been known for many years [2]. However, histo-
logical studies on the effects of histamine on human skin have 
concentrated more upon responses in allergic rather than nor-
mal, nonallergic subjects [3,4]. Intradermal injections of hista-
mine or allergen in allergic individuals were found to cause 
inflammation of considerable intensity with a leukocyte infil-
trate as early as 15 min after injection [3]. At 20-35 min, the 
majority of cells was eosinophils. In nonallergic subjects no 
- similar responses were noted at intervals up to 65 min following 
injection [3]. Mast cell changes were not assessed. In atopic 
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subjects, eosinophil responses to intracutaneous injections of 
the mast-cell degranulating agent, compound 48/80 (48/80), 
and ragweed were found to be similar [4]. These authors noted 
an eosinophil infIltrate in 2 of 4 subjects 48 ill' after i.c. injection 
of 700 p.g of 48/80. No comment was made of the effects of 
either histamine or 48/80 on other leukocytes, such as neutro-
phils, or on various morphological features such as fibrin dep-
osition. Mast cell degranulation was assessed indirectly by 
noting the reduction in numbers of stainable cells. In further 
experiments [5] few perivascular neutrophils without eosino-
phils or fibrin were demonstrated in the skin in 2 of 3 normal 
subjects 4 hr after a single intradermal injection of 0.55 /Lg 
histamine. 
In order to extend these preliminary observations [3-5] we 
have undertaken a microscopical study in normal skin of se-
quential changes occurring over several hr after single bolus 
injections, repeated boluses and prolonged infusions of both 
histamine and 48/80. To obtain maximum definition by light 
microscopy, I-p.m epoxy-resin sections were prepared from bi-
opsy material that had been processed according to techniques 
more frequently used for electron microscopy. We employed a 
semiquantitative scoring system modelled on that of Dvorak et 
al [6] to assess and compare histological changes seen in differ-
ent skin samples. Electron microscopy was used to investigate 
characteristics of the leukocyte infiltrate, the vascular changes 
and the type and degree of mast cell degranulation. 
MATERIALS AND METHODS 
Sixteen healthy subjects and 19 patients with localized skin disease 
aged 18-73 yr, agreed to participate with informed consent. The type 
of skin disease was variable, the largest groups comprising patients with 
pompholyx in a clinkally quiescent stage, viral warts, and stasis ulcers. 
Patients with atopic eczema or psoriasis were not included. The total 
and differential white blood cell counts were normal in all subjects, 
both patients and normal, who were tested. Blood counts were not 
obtained in 3 health y subjects. All anti-inflammatory and antihistamine 
drugs were withdrawn at least 24 hr before the experiments. Procedul'es 
were carried out between 8 and 12 AM. 
Test Solutions 
Histamine: Histamine acid phosphate (B.D.H. Chemicals Ltd., En-
field, Middlesex, England) dissolved in phosphate buffered saline 
(PBS), pH 7.4, was passed through a sterile filter of pore size 0.54 11m 
(Millipore (UK) Ltd., London N.W.1O., England) and stored at -20°C. 
The concentration of the stock solution was 10-2 M histamine base. 
Compound 48/80: Compound 48/80 (Sigma London, Chemical Co. 
Ltd., Poole, Dorset, England) was dissolved in PBS, pH 7.4 to a final 
concentration of 200 Jig/mJ and sterilized and stored as above. 
406 
Control: PBS, pH 7.4. 
Injection Techniques 
All injections were given intradermally into the flexor aspect of the 
forearm 5-7 cm from the elbow crease, with a sterile disposable tuber-
culin syringe (Gillette Surgical, Isleworth, Middlesex, England) and a 
25-gauge needle or Butterfly infusion set (Abbot Ireland Ltd., Sligo, 
Republic of Ireland). 0.05 ml of the stock solutions (histamine, 50 Jig; 
48/80 10 Jig) was injected either as a single bolus or as a repeated bolus 
every 15 min for 2 hr into the same site. The dose of histamine was 
chosen because it caused a weal and flare which were a convenient size 
to measure and biopsy. The size of the reaction to 10 Jig 48/80 was 
similar. Constant infusions of the test substances were given at a rate 
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of 0.12 mllhr for 4 hr using an electrically driven Sage Syringe pump, 
model 341 (Orion Research Incorporated, Cambridge MA 02139, 
U.S.A.). The dose of histamine was 120 j.Lg/hr and of 48/ 80, 24 j.Lg/ hr. 
Control injections of PBS were given as a single OJ· repeated bolus (of 
0.05 ml) or by infusion for 4 hr. 
P unch biopsies of 3 mm in diameter were taken from the weals (or 
where weals had been present) and away from the needle tract after 
inflltrating the surrounding skin with 1.0% lignocaine but without 
epinephrine. The samples were taken 15-30 min, 4 hr, and 16-24 hr 
after single boluses of histamine, 48/ 80 and PBS and immediately after 
8 repeated boluses of histamine or 4 hr infusions of histamine, 48/80 
and PBS. Control samples were also taken from uninjected skin in 4 
healthy subjects. 
All samples were immediately immersed in half-strength Karnovsky 
flxative [7] in 0.1 M cacodylate buffer and divided in to three or foUl" 
blocks of approximately equal size. Processing was then carried out 
according to the method described previously [8]. Semi thin Epon 
sections (1-j.LID thick) cut perpendiculru· to the skin surface were stained 
with basic fuchsin and methylene blue [9] and mounted in immersion 
oil for light microscopic studies [8]. 
;0 Sections from at least two blocks from each biopsy were examined. 
The slides were coded with a random number and assessed by one 
observer (MPJ) who had no knowledge of the experimental detail. 
Eleven histological features were assessed semiquantitatively. Each 
feature was given a score of 0-4 depending on the degree of change, 
with 0 representing no change; 1, slight; 2, moderate; 3, marked; and 4, 
very extensive. Mast cells were identified by their cytoplasmic granules 
which stained bright red or purple [8]. Degranulation was considered 
to have occurred when free granules could be observed around the 
cells. The cellular infiltrate was scored using the following criteria: 1 
= 1-5 cells in and around any vessel, 2 = 5-20 cells, 3 = 20-100 ceUs, 4 
= >100 cells. Since a small number of mononuclear cells may be seen 
ru·ound blood vessels in normal skin we scored 5-20 mononuclear cells 
around any vessel as 1 and 20-100 cells as 2. 
~ For electron microscopy, the blocks were retrimmed and ultra-thin 
sections were cut with diamond knives on a LKB 1 or a Reichert OMU 
4 ultramicrotome, collected on grids coated with pru·lodion and cru·bon, 
stained with uranyl acetate and lead citrate, and examined in an AEI 
EM6B electron microscope. 
RESULTS 
Weal and Flare Characteristics 
The weal and flare caused by 50 p.g histamine and 10 p.g 48/ 
80 were similar in size but different in time course. A single 
bolus of histamine produced a weal and flare within 5 min, 
reaching a maximum size (expressed as a measurement of area, 
determined by planirnetry) at 10-15 min, and disappearing by 
40-60 min. The reaction induced by 48/ 80 persisted in maxi-
mum size for 15-30 min and was still present, though smaller, 
at 100 min, and in most cases had disappeared by 120 min. 
Repeated boluses of histamine led to augmentation of the 
initial weal and flare. Maximum response was seen at 40-60 
min (after 3- 4 injections) and was characterized by a confluent 
erythema throughout the whole reaction site and by loss of the 
sharp margins of the weal. The reaction then began to fade in 
spite of continuing injections. Slight edema and erythema were 
still present at 2 hr. 
The time course of the reactions associated with constant 
infusions of histamine or 48/80 was similar to that for repeated 
TABLE 1. Early effects of bolus injections of histamine and Compound 48/ 80 compa.red with controls 
Parameter 
Dermal edema 
Blood vessel dilatation 
Lymphatic dilatation 
Mast cell degranulation 
Fibrin deposition 
Nerve edema 
Cellulru· infiltration 
Neutrophil 
Eosinophil 
Lru·ge mononucleru· cell 
Lymphocyte 
Erythrocyte 
" Phosphate buffered saline. 
/> Time biopsy taken after injection. 
C Number of subjects studied. 
"Mean. 
Parameter 
Dermal edema 
Blood vessel dilatation 
Lymphatic dilatation 
Mast cell degranulation 
Fibrin deposition 
Nerve edema 
Cellulru· infiltration 
Neutrophil 
Eosinophil 
Large mononucleru· cell 
Lymphocyte 
Erythrocyte 
TABLE II. 
" Time biopsy taken after injection. 
/> Number of subjects studied. 
' Mean. 
1 2 3 
Single bolus Single bolus Single bolus 
histamine 48/ 80 PBS " 
15-30 min" 15-30 min 15 min 
(8) ' (4) (3) 
1.48" 0.75 0 
0.77 0.5 0.56 
1.63 1.5 0.33 
1.06 1.38 0.33 
0.69 1.13 0 
1 0.38 0 
0.31 1.13 0 
0.19 0.5 0 
0.63 0.5 0 
0 0.38 0 
0 0 0 
Later effects of bolus injection of histamine a.nd Compound 48/ 80 
5 6 7 
Single. bolus Single bolus Single bolus 
histamine histamine 48/ 80 
4 hr " 16 hr 4 hI" 
(2)h (2) (3) 
OC 0.42 0.61 
o 0.59 1.22 
0.5 1.5 0.5 
0.25 0.5 0.83 
0.75 0.5 0.67 
o 0.25 0.17 
o 
o 
o 
o 
o 
o 
o 
1 
0.75 
o 
1.83 
0.67 
0.17 
0.83 
o 
4 
Uninjected 
controls 
(4) 
0.04 
0.21 
0 
0.5 
0 
0 
0 
0 
0.13 
0.5 
0 
8 
Single bolus 
48/ 80 
24 hr 
(2) 
0.33 
0.5 
o 
0.75 
1 
0.75 
2 
2.25 
1 
1.25 
o 
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TABLE III. R esults of rep ealed bolus and infusion exp eriments 
9 10 11 12 
Repeated bolus of Infusion of Infusion of Infusion of 
PBS Parameter histamine histamine 48/80 
2 hr " 4 hr 4 hI' 4 h,' 
(5)" (4) (3) (3) 
Dermal edema 1.17 c 1.04 0.56 0.22 
0.17 
0.33 
0.83 
o 
Blood vessel dila tation 
Lymphatic dilatation 
Mast cell degranulation 
Fibrin deposition 
Nerve edema 
0.77 1.08 0.5 
0.9 1.88 0.67 
0.8 1.25 1.67 
1.4 1.25 1.5 
0.2 0.13 0.33 o 
Cellular infIltration 
Neutrophil 
Eosinophil 
Large mononuclear cell 
Lymphocyte 
Erythrocyte 
" Time biopsy taken after start of experiment. 
b Number of subjects studied. 
C Mean. 
0.4 
0.4 
0.4 
0.2 
o 
1.25 
0.5 
0.5 
0.75 
o 
2.17 
0.5 
0.33 
0.33 
o 
0.33 
o 
0.33 
o 
o 
TABLE IV. Statistical analysis" 
Parameter 3v4 b Iv3 
Dermal edema < 0.01" 
Blood vessel dilatation 
Lymphatic dilatation 
Mast cell degranulation <0.045 
Fibrin deposition 
Nerve edema <0.025 
Cellular infIltration 
Neutrophil 
Eosinophil 
Large mononuclear cell < 0.025 
Lymphocyte 
Erythrocyte 
" Ma nn-Whitney U-test. 
II Comparison of groups listed in Tables I-III. 
C Not significan t.. 
d p value. 
2v3 
< 0.03 
<0.03 
boluses of histamine. By 4 hr, there was either no obvious 
clinical reaction or at most, minimal swelling and erythema. No 
delayed reactions such as recrudescence of painful edema and 
erythema [10] were observed during the 24 hr following injec-
tion of either histamine or 48/80. 
Intradermal injections of PBS produced transient small blebs 
with ' no associated weal and flare . Slight swelling was still 
palpable at 15 min. Infusions of PBS caused minimal swelling. 
with no weal or flare. 
Light Microscopic Observations 
The histological findings are summarized in Tables I, II, and 
III which include the mean scores obtained for each I)f the 11 
parameters for each group of experiments. There was no ob-
vious qualitative or quantitative difference in the responses to 
the test reagents shown by the normal subjects compared with 
1 v2 9vl lOvl 10vl2 llvl2 llv2 
< 0.03 
<0.03 
< 0.03 < 0.03 
< 0.03 0.05 
<0.015 < 0.025 
<0.04 
0.05 
< 0.025 <0.005 < 0.03 
patients with localized disease. The results of statistical analysis 
using the Mann-Whitney U-test are given in Table IV . 
Single Bolus of Histamine (Tables I and II) 
At 15 min, the presence of edema, identified as pink amor-
phous material separating collagen bundles, was a striking 
feature in most biopsies, particularly in the middle and upper 
dermis (Fig lA). Both venules and arterioles were dilated. The 
endothelium, though never obviously disrupted, was often swol-
len (Fig lA). Lymphatics were widely dilated and filled with 
pink-staining material similar in appearance to edema. The 
degree of lymphatic dilatation appeared to be related to the 
amount of dermal edema. Small numbers of intravascular neu-
trophils and eosinophils and perivascular mononuclear cells 
were seen occasionally. Plasma cells and basophils were not 
found. Mast cell degranulation (Fig IB) was constant but URU-
FIG 1. All illustrations are photomicrographs of 1 /.1m thick Epon sections stained with methylene blue and basic fuchsin [8]. A, 15 min after 
a single bolus injection of histamine. There is swelling of the endothelium of 2 small blood vesse ls (BV) near the center of the fie ld . Edema (ED) 
surrounds these vessels and a nerve (NV) whose endoneurium is edematous. Bar = 20 /.1m. B, 15 min after a single bolus injection of histamine. 
-Two degranulating mast cells are shown. Granules are pres~nt both within and outside each cell. Bar = 10 p.m. C, 15 min after repea ted bolus 
injection of histamine. A small arterio le, (A), venule (V) and nerve (NV) , are surrounded by edema (ED). Neutrophils (NP) and eosinophils (EO) 
can be seen within the lumen and wall of the venule. Bar = 20 p.m. D, 15 min after a single bolus injection of 48/80. A dilated lymphatic (L) lies 
adjacent to a venule which is also dilated and is shown in longitudinal section. The endothelium of the venule appears swollen. Numerous 
neutrophils are present within the vessel lumen and wall. T\Vo eosinphils (EO) can be seen just outside the vessel wall. Bar = 20 p.m. E, 15 min 
after a single bolus injection of 48/80. A dilated arteriole (A.) and venule (V) are shown next to a nerve (NV) at the centre of the field. The 
endothelium of the venule is swollen. Numerous neut rophils ~an be observed in and around the venule wall. Several compacted neutrophils, some 
of which are undergoing lysis, are present in the lumen. BtlI' = 20 p.m. F , 24 hI' after a single bolus injec tion of 48/80. Numerous eosinophils 
surround vessels in .the mid-dermis. Bar = 20 p.m. G, Mid-dermis immediately after 4 hI' infusion of 10- 2 M histamine. Three blood vessels are 
shown in cross-section. There is a slight perivascular infiltrate of neutl'ophils, rnonocytes and lymphocytes. Some leukocytes can be seen in the 
wall of a venule (V) whose endothelium is swollen. Fibrin (p) is deposited away from the immediate perivascular zone. Bar = 20 p.m. H , D eep-
dermis following a 4 hr infusion of compound 48/80. Note th~ profusion of neutrophils surrounding a nerve (NV) , arterio le (A) and 2 venules (V). 
Arrow indicates mast cell which has been pa rtially depleted of granules. Bar = 20 /.1m. 
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FIG 2-3. 
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ally slight. Degranulating cells could be found close to vessels 
or away from vessels and adjacent to other mast cells that 
seemed quite normal and full of granules. There appeared to be 
no correlation between the site of the de granulating mast cell, 
the degree of degranulation, and the extent of the sW'rounding 
edema. Fibrin, identified as fine, pW'ple-staining fibrillary ma-
terial deposited between collagen bundles (Fig IG, see below), 
was frequently seen and was most prominent in middle and 
deep dermis. It was uncommon in the immediate perivascular 
space and was never seen in the papillary region. Where dermal 
edema was maJ.·ked, swelling of the endoneurium and larger 
myelinated axons of cutaneous nerves was noted (Fig. lA). 
At 4 hr after injection of histamine (Table II) vasculaJ.· 
dilatation, endothelial swelling and dermal edema had dimin-
ished. Fibrin deposition and the occasional leukocyte were still 
present at 4-16 hr. 
Repeated Boluses and Infusion of Histamine (Table III) 
The majority of changes caused by repeated boluses and 
infusions of histamine were similar. CompaJ.·ed with the effects 
of a single bolus of histamine, dermal edema was less prominent 
whilst fibrin deposition was more extensive (Fig IG). The main 
difference affected the cellular infiltrate. In all 4 of the biopsies 
following infusion of histamine there was a light infiltration of 
neutrophils and to a lesser extent, eosinophils, in and around 
venules (Fig IG) . In 2 of 5 biopsies following repeated boluses 
of histamine a similar inflltration was seen (Fig IC) . 
Single Bolus of Compound 48/80 (Tables I and III) 
At 15-30 min after injection, blood vessel and lymphatic 
dilatation, endothelial swelling and dermal edema were similar 
to those caused by a single bolus of histamine. Fibrin deposition 
was more extensive and more mast cells were degranulated. In 
2 of 4 biopsies a moderate to dense neutrophil and eosinophil 
infIltrate was present in and aJ.·ound venules in the mid- and 
deep dermis (Fig ID and E) . Many leukocytes both inside and 
outside vessel lumina were disrupted and degranulated (Fig 
IE). PerivasculaJ.· basophils, plasma cells and erythrocytes were 
not found . 
At 4 hI' (Table II) the infIltration of neutrophils, eosinophils 
and lymphocytes aJ.·ound vessels was more extensive. At 24 hI' 
many white cells were still present, and in one biopsy a heavy 
inf'utration of eosinophils was seen (Fig IF). 
Infusion of Compound 48/80 (Table III) 
In 2 of 3 biopsies, all changes caused by a single injection of 
48/80 were observed namely, blood vessel and lymphatic dila-
tation, dermal edema, fibrin deposition and leukocyte inflltra-
tion (Fig IH). While many mast cells were degranulated a 
compaJ.·able number appeared quite normal and without fea-
tures of degranulation. 
Controls (Tables I and III) 
Following bolus injections or infusions of PBS there was 
slight vasculaJ.· dilatation. Fibrin deposition did not occw'. After 
infusion of PBS sca!1ty neutrophils were seen aJ.·ound a deep 
dermal vessel in one section. Slight mast cell degranulation was 
found in a few sections of normal uninjected skin. 
Electron-microscopic Observations 
Mast cell degranulation: In general 2 types of mast cell 
degranulation were noted and will be described in greater detail 
elsewhere [11]. In the fIrst (Type 1), the main cell body was 
intact and the cytoplasm was filled with electron-dense granules 
exhibiting normal ultrastructural featW'es including scroll-like 
configW'ations of the lamellae. DischaJ.-ged granules, possibly 
derived from the vacuolated portions of mast cells, were present 
in the extraceliulaJ.· space. The size, electron density, and la-
mellate substructW'e of these dischaJ.·ged granules were similaJ.· 
to the normal intracellular granules. An almost invariable find-
ing was the presence of appaJ.·ently intact perigranular mem-
branes around these extracellular granules. 
In the second type (Type 2) of mast cell degranulation, the 
granules, especially those neaJ.· the plasma membrane, became 
laJ.·ger than normal and lost much of their electron density and 
characteristic substructW'e. Fusion occurred between adjacent 
perigranular spaces with the formation of large membrane-
bounded cavities containing the altered granules. Communica-
tion between these cavities and the extracellulaJ.· space was 
common and the altered granules were discharged outside the 
cell without their perigranular membranes. 
Each type of mast cell degranulation was seen with both 
histamine and 48/80 reactions. However, with histamine, Type 
1 was more common; whereas, with 48/80, Type 2 occurred 
more frequently. Electron microscopy confirmed that, after 
bolus injections or infusions of 48/80, numerous mast cells 
showed no degranulation changes and thus none of the mor-
phological features expected to occur during histamine release. 
Vascular changes: In all blocks in which dermal edema was 
identified as a pink-staining material by light microscopy, a fine 
granulaJ.· deposit of moderate electron density was found by 
electron microscopy. In none of the experiments did the endo-
thelium of either blood vessels or lymphatics show evidence of 
shrinkage, lysis or other forms of cellular disruption. However, 
moderate endothelial swelling was constantly observed in blood 
vessels, especially venules, after histamine bolus, histamine 
infusions or 48/ 80 injection (Fig 2 and 3). The junctions between 
blood vasculaJ.· endothelial cells remained intact and no obvious 
gaps were seen in the endothelium or surrounding basal lamina 
except where leukocyte ~iapedesis was occW'ring (Fig 2). No 
focal dense deposits resembling, for example, those thought to 
be immune complexes [12], were seen in either histamine or 
48/80 reactions. By contrast, the lymphatic endothelium was 
often discontinuous with 1aJ.·ge gaps forming between adjacent 
endothelial cells. 
Leulwcyte infiltrate and fibrin deposition: In all instances 
where diapedesis of leukocytes occurred (see above) the white 
cells exhibited vaJ.·iable ultrastructural changes. When the infil-
trate was moderately heavy the neutrophils frequently showed 
vaJ.·ying degrees of cytolysis: the nucleus often stayed intact but 
the cytoplasm became fragmented with its granules dischaJ.·ged 
into the extracellular space. Neutrophil cytolysis was relatively 
mild in the histamine repeated-bolus or infusion experiments 
but was much more marked in the 48/80 reactions, even after 
a single bolus of 48/80, where advanced leukocyte disruption 
with 'spillage of granules was noted actually within the lumina 
of both arterioles and venules (Fig 2, 3). The changes occurring 
in eosinophils were different: the cells rarely disrupted with 
either histamine or 48/80. Their granules, while usually re-
maining inside the cell, were almost invaJ.·iable altered (Fig 3). 
The granule matrix became electron-lucent and vacuolated, 
while the crystalline core usually stayed intact. The small 
number of granules in the extracellulaJ.' space probably derived 
from the disintegrating cells. 
The deposition of fibrin was confIrmed by identifying typical 
strands of electron-dense material usually enmeshed among 
collagen fibrils and often where leukocytoclasis had occuned. 
FIG 2. Mid -dermal venule after a single bolus of compound 48/ 80. The endothelial cells (En) are not disrupted and the organelles and ftlaments 
appear normal. The edematous swelling of the endothelium is indicated by the general low electron density of the cytoplasm. Numerous 
neutrophils (Np 1-4) are undergoing diapedesis. The basal lamina (arrows) apperu's normal. Numerous free neutrophil granules (G) are present 
in the vessel lumen. Bar = 2 /Lm. 
FIG 3. Detail of pru·t of a dermal venule after a bolus injection of compound 48/ 80. A mass of cellular debris comprising mostly neut.rophil 
nucleru' material (ND) and granules (G) is present in the lumen. The endothelium (En) apperu's structurally undamaged. An intact neutrophil 
(Np) and an eosinophil (Eo) with several altered granules, are present in the waH of the vessel. Bar = 2 /Lm. 
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Characteristic cross-banding of about 20 nm periodicity was not 
usually observed. 
DISCUSSION 
There are several advantages of the techniques used in the 
present study over conventional histological methods employ-
ing formalin fixation and paraffin embedding. Tissue preserva-
tion is superior which is a critical consideration in the assess~ 
ment of small but important histological changes. Protein fix-
ation is especially good, thus allowing in situ identification of 
fibrin and edema. Moreover, the Huber stain [9] in contrast to 
most others used on semithin plastic sections, such as Giemsa 
or toluidine blue, is polychromatic and will differentiate various 
tissues such as collagen and elastic. The scoring system which 
we used to grade histological features in a "blind" fashion 
provides a convenient, objective and semi-quantitative method 
of analysing the slides. Its strength lies more in its value in 
allowing trends to emerge; the relatively small number of sta-
tistically significant values must be viewed in the light of small 
sample sizes and the rather limited range between the lowest 
and highest scores allowed for each parameter. 
The most striking difference between the early and later 
effects of histamine and 48/80 was in the degree of the perivas-
cular leukocyte infIltration. As soon as 15-30 min after 48/80, 
there was, in 2 out of 4 samples, a moderate infiltrate of 
neutrophils and eosinophils. The number of both types of 
granulocyte increased slightly at 4 hr and by 24 hr the cellular 
infIltration was even more marked. By contrast, after injection 
of histamine the inftltration of neutrophils and eosinophils was 
absent or slight at 15-30 min and absent at 4 hr and at 16 hr. 
We think that the greater infIltration of neutrophils and 
eosinophils following 48/80 administration is likely to be due to 
the influence of mediators other than histamine released from 
dermal mast cells. This conclusion was also reached by Atkins, 
Green, and Zweiman [4]. Chemotactic factors for eosinophils 
and neutrophils possibly derived from skin mast cells have been 
recovered from venous blood draining cold-challenged skin in 
cold urticaria [13], and skin exposed to ultraviolet radiation in 
solar urticaria [14]. 
By light microscopy, we could assess cell degranulation only 
by observing free granules in the interstitial space around intact 
mast cells; we felt that this appeamnce suggested that the 
granules had been discharged from the cell they surrounded. 
However, electron microscopy revealed that 2 principal types 
of degranulation were possible. In the first, the granules were 
expelled usually unchanged, outside the cell body. In the sec-
ond, most of the granules remained in large membrane-bounded 
vacuoles or cavities within the cytoplasm of the mast cell and 
only a few were discharged from the cell. This second type 
corresponds much more closely with the morphological events 
known to occur during histamine release evoked by antigen or 
48/80 in the rat [15]. It is highly unlikely that this mast-cell 
change can be properly recognized by light microscopy alone 
thus highlighting the importance of correlative ultrastructural 
studies where mast cell degranulation needs assessing [11]. 
Furthermore, the first type of degranulation might correspond 
more to cell disruption or lysis than true physiological degran-
ulation associated with mediator release. Each type of change 
occurred with both histamine and 48/80 but proportionately 
. more cells in the histamine reactions were affected by the first 
type, whereas 48/80 caused relatively more Type 2 degranula-
tion. 
The possibility that the observed effects of 48/80 are not due 
to its action on mast cells have not been excluded. In the rat, 
48/80 has been shown to be capable of evoking release of 
eosinophil chemotactic factor from peritoneal mast cells with-
out itself being chemotactic for eosinophils [16J. 
Explanations for the presence of apparently normal fully 
granulated mast cells after a 4 hr infusion of 48/80 include the 
possibility that different populations of mast cells in human 
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skin have different susceptibilities to the action of 48/ 80, or 
that at some stage of maturation or regranulation, the mast cell 
becomes unresponsive to the action of 48/80. Support for the 
latter theory comes from recent in vitro studies in the mouse 
which have shown that mast cells will regranulate even in the 
continuing presence of 48/80 and will remain relatively refrac-
tory to further degranulation by 48/80 for several days [17]. 
Irregular diffusion of 48/80 through the dermis from the needle 
tip is a possible cause, but the proximity of degranulating cells 
to unaltered cells makes this explanation unlikely. The pre-
sumption that intradermal injection of 48/80 will fully degran-
ulate a local population of mast cells should now be refuted. 
There is conflicting evidence whether histamine attracts eo-
sinophils [18]. In vitro, histamine is chemokinetic for both 
human eosinophils [18,19J and neutrophils [20]. The present 
study suggests that histamine in vivo is unlikely to be signifi-
cantly chemotactic for these leukocytes. We found no dose-
related differences when examining the effects of infusions of 
histamine at different concentrations (10- 6 or 10- 5 M compared 
with 10- 2 M) on perivascular leukocyte accumulation (unpub-
lished observations). 
The similarity in the sizes of the weal and flare reactions 
caused by 50 fig histamine and 10 fig 48/80 suggests that the 
differences in the responses to these substances are probably 
not simply dose-related. The slight difference in the time 
courses of these reactions may be associated with the greater 
leukocyte or fibrin accumulation after 48/80 injection. 
Fibrin deposition was not reported in earlier studies on his-
tamine weals [3-5J but was a constant finding in the present 
investigation. Its absence from the immediate perivascular zone 
has also been observed in delayed hypersensitivity lesions [6] 
and could be due to the fibrinolytic activity inherent in normal 
blood vessels [21,22]. Neutrophils [23,24] and eosinophils [25] 
can activate fibrinolysis and may also contribute to the removal 
of fibrin. Fibrin and fibrin degradation products can attract 
leukocytes [26J and thus may participate in leukocyte accu-
mulation seen in the present study. They may also account for 
the "persistence" of histamine weals [27], since histamine might 
induce the formation or liberation or other vasoactive materials 
in skin [27]. 
The presence of early vessel changes and leukocyte degran-
ulation and lysis following injections of 48/80 was an unexpected 
finding. Similar morphological changes have been observed in 
skin of patients with essential acquired cold mticaria following 
multiple cold challenge [28] and also in the Arthus reaction in 
laboratory animals, in which immunological mechanisms, par-
ticularly immune complex deposition and complement activa-
tion, are thought to trigger neutrophil accumulation and sub-
sequent vessel damage [12]. We do not think in the present 
study that complement is responsible for either mast cell de-
granulation [29,30J or leukocyte infiltration [31J since neither 
histamine nor 48/80 in the concentrations used in om experi-
ments activates complement (as assessed by the ability of these 
substances to cause consumption of total haemolytic comple-
ment, to produce C3a and C5a and to convert C3 to C3b [32]) 
(Ramanathan VD, personal communication). 
It seems possible that swelling of the endoneurial space and 
vacuolation of larger myelinated axons in cutaneous nerves 
particularly when edema is prominent, could cause itch or pain. 
Mast cells occurring in the intranemial space of myelinated 
dermal nerves [8] presumably are capable of degranulation. 
We conclude that marked dermal changes may occur under 
the influence of histamine or 48/80. Histamine in vivo, does not 
appear to have a significant chemoattractant effect on eosino-
phils or neutrophils, but other mast cell-derived mediators may 
have a more important influence on the activation of these 
leukocytes in acute inflammatory reactions. Our findings sug-
gest that some forms of cutaneous vasculitis may be mediated 
by nonirnmunological processes, or at least, vasculitic changes 
may be mimicked experimentally by the influence of pharma-
cological agents. 
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